1. Executive Summary |
2. Global Nutrigenomics Market Introduction |
2.1. Global Nutrigenomics Market – Taxonomy |
2.2. Global Nutrigenomics Market –Definitions |
2.2.1. Product Type |
2.2.2. Sample Type |
2.2.3. Application |
3. Global Nutrigenomics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Nutrigenomics Market Dynamic Factors - Impact Analysis |
3.6. Global Nutrigenomics Market – Competition Landscape |
4. Global Nutrigenomics Market Analysis,2017-2021 and Forecast, 2022-2028 |
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Nutrigenomics Market, By Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1. Reagents |
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Kits |
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Services |
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Nutrigenomics Market Forecast, By Sample Type, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
6.1. Saliva |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Buccal Swab |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Blood |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Nutrigenomics Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1. Diabetes |
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Obesity |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Gastrointestinal |
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Woman's Health |
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Neurological |
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Others |
7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
8. Global Nutrigenomics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1. North America |
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application and Region, 2022-2028 |
9. North America Nutrigenomics MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1. By Product Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Reagents |
9.1.2. Kits |
9.1.3. Services |
9.2. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Saliva |
9.2.2. Buccal Swab |
9.2.3. Blood |
9.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Diabetes |
9.3.2. Obesity |
9.3.3. Gastrointestinal |
9.3.4. Woman's Health |
9.3.5. Neurological |
9.3.6. Others |
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. USA |
9.4.2. Canada |
9.5. North America Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application, and Country, 2022-2028 |
9.6. North America Nutrigenomics Market Dynamics – Trends |
10. Europe Nutrigenomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.1. By Product Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Reagents |
10.1.2. Kits |
10.1.3. Services |
10.2. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Saliva |
10.2.2. Buccal Swab |
10.2.3. Blood |
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Diabetes |
10.3.2. Obesity |
10.3.3. Gastrointestinal |
10.3.4. Woman's Health |
10.3.5. Neurological |
10.3.6. Others |
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Rest of Europe |
10.5. Europe Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application, and Country, 2022-2028 |
10.6. Europe Nutrigenomics Market Dynamics – Trends |
11. Asia-Pacific Nutrigenomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
11.1. By Product Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Reagents |
11.1.2. Kits |
11.1.3. Services |
11.2. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Saliva |
11.2.2. Buccal Swab |
11.2.3. Blood |
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Diabetes |
11.3.2. Obesity |
11.3.3. Gastrointestinal |
11.3.4. Woman's Health |
11.3.5. Neurological |
11.3.6. Others |
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Japan |
11.4.2. China |
11.4.3. India |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application, and Country, 2022-2028 |
11.6. Asia-Pacific Nutrigenomics Market Dynamics – Trends |
12. Latin America Nutrigenomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
12.1. By Product Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Reagents |
12.1.2. Kits |
12.1.3. Services |
12.2. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Saliva |
12.2.2. Buccal Swab |
12.2.3. Blood |
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Diabetes |
12.3.2. Obesity |
12.3.3. Gastrointestinal |
12.3.4. Woman's Health |
12.3.5. Neurological |
12.3.6. Others |
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Argentina |
12.4.4. Rest of Latin America |
12.5. Latin America Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application, and Country, 2022-2028 |
12.6. Latin America Nutrigenomics Market Dynamics – Trends |
13. Middle East and Africa Nutrigenomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
13.1. By Product Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Reagents |
13.1.2. Kits |
13.1.3. Services |
13.2. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Saliva |
13.2.2. Buccal Swab |
13.2.3. Blood |
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Diabetes |
13.3.2. Obesity |
13.3.3. Gastrointestinal |
13.3.4. Woman's Health |
13.3.5. Neurological |
13.3.6. Others |
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. Israel |
13.4.3. South Africa |
13.4.4. Rest of MEA |
13.5. MEA Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application, and Country, 2022-2028 |
13.6. MEA Nutrigenomics Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Sample Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. WellGen Inc |
14.2.2. Metagenics Inc. |
14.2.3. Genomix Nutrition Inc. |
14.2.4. Nutrigenomix |
14.2.5. NutraGene |
14.2.6. XCODE Life Sciences Pvt. Ltd |
14.2.7. Cura Integrative Medicine |
14.2.8. NutriProCan |
14.2.9. GX Sciences, Inc. |
14.2.10. Vitl |
15. Research Methodology |
16. Key Assumptions and Acronyms |
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.